RNA sequence analysis has shown that plasma kallikrein and bradykinin precursors are expressed at increased levels and that degrading enzymes (e.g. ACE) are substantially downregulated in patients with COVID-19 [5]. This evidence concerns the gene KNG1 and COVID-19.